Work for a Member company and need a Member Portal account? Register here with your company email address.
Researchers created a water-soluble version of an important bacterial enzyme, which can be used in drug screens to identify new antibiotics.
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.